Terminated NA INTERVENTIONAL 2-arm NCT04091191

Evaluation of a Nutraceutical for Endometriosis Pain Relief

A Single Center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of a Specialized Nutraceutical for Endometriosis

Sponsor: Metagenics Europe

Conditions Endometriosis

Interventions Meta19.01

Updated 7 times since 2019 Last updated: Mar 14, 2023 Started: Oct 13, 2021 Primary completion: Dec 16, 2022 Completion: Dec 16, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient recruitment

Other Endometriosis trials with similar outcome

Browse all Endometriosis trials

A NA clinical study on Endometriosis, this trial is terminated or withdrawn. The trial is conducted by Metagenics Europe and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Apr 2023 — Jul 2024 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Mar 2023 — Apr 2023 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Mar 2021 — Mar 2023 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting NA
Oct 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Metagenics Europe

Data source: Metagenics Europe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mons, Belgium